Human parvovirus is a recognised cause of arthritis.' A recent report suggests that it may also cause brachial plexus neuropathy.2 We describe a patient who presented with both articular and neurological manifestations of infection.
A previously fit 23 year old nurse presented in January 1986 with pain in both arms. Two weeks earlier she had noticed an erythematous rash which spread from the legs to the abdomen and arms but spared the upper trunk and face. Within hours she developed pain in the ankles and knees, and by 48 hours she had pain in the neck and shoulders, weakness of the arms, and numbness and dysaesthesia of the right forearm. There was no history of recent immunisations. She had in the past been immunised against poliomyelitis.
On examination she was found to be alert with no fever or meningeal irritation. The rash was no longer apparent and the joints were normal. There was pronounced tenderness of both trapezius muscles, deltoids, and biceps and severe weakness of shoulder abduction. Both biceps reflexes and the left supinator reflex were reduced. An area of sensory loss was detected over the radial border of the right forearm.
Full blood count, erythrocyte sedimentation rate, biochemical profile, blood glucose concentration, and serum creatine kinase activity were normal. An The pain resolved within four weeks but severe wasting of both deltoids and the left supjaspinatus and infraspinatus and right biceps muscles occurred and the biceps and supinator reflexes were completely lost. Six months later wasting and weakness had improved and sensory loss had recovered.
Comment
Acute neuropathy of the brachial plexus (neuralgic amyotrophy) is characterised by the sudden onset of pain around the shoulder girdle followed by weakness and wasting of periscapular and arm muscles. Sensory impairment is common. Complete recovery taking up to three years is the rule.3 An association with various inoculations, infections, and surgical procedures has been described. 3 Viraemia due to human parvovirus was first described in 1975, and the virus has subsequently been incriminated as a cause of aplastic crises in people with various chronic haemolytic anaemias, of erythema infectiosum, and of arthralgia or arthritis.45 There have been no reports of neurological illness other than brachial plexus neuropathy due to parvovirus in man.
Our patient showed serological evidence of recent parvovirus infection coincident with the development of brachial plexus neuropathy. There was also evidence of adenovirus infection occurring between the two tests; adenovirus, however, have rarely been implicated as a cause ofarthralgia and never as a cause of brachial plexus neuropathy, nor did the patient recall typical adenovirus symptoms during the period. From the clinical and laboratory findings we believe that parvovirus was the cause of her illness and may therefore be implicated as a cause of brachial plexus neuropathy. We suggest that testing for parvovirus should be undertaken in cases of brachial plexus neuropathy. Stopping the calcium infusion while increasing oral treatment resulted in symptomatic hypocalcaemia and florid evidence of depersonalisation. The calcium in the dialysis fluid (about 1-6 mmol/l) was therefore supplemented with a 10% solution of calcium chloride (20 mmol per two litre dialysis bag; added under sterile laminar flow, and the serum calcium concentration entered the normal range for the first time after operation. Thereafter, intraperitoneal calcium 60 mmol/day, oral calcium gluconate 6 g/day, and 1,25-dihydroxyvitamin D3 1-5 ptg/day maintained serum calcium concentration in the low normal range.
Absorption of calcium from the peritoneal cavity was calculated at intervals
